Mylan Inc. (Nasdaq: MYL), the generic and specialty pharmaceutical company, appointed Heather Bresch Chief Executive Officer effective January 1, 2012. Heather, who has been with Mylan since 1992, had been President of the Company. Bresch was appointed to the Board of Directors of Mylan in March 2011. Read more in the Company announcement.
Update: Watch Heather discuss the global drug industry.